July 26, 2023
by Andrii Buvailo
Biopharma insight
AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with …
Nov. 3, 2023
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
July 11, 2023
by Andrii Buvailo
Biopharma insight
(Last updated: July 2023) Pharmaceutical companies are increasingly outsourcing research activities to academic institutions, tech-driven companies, and private contract research …
April 9, 2024
by Bohdana Sokolova
Biopharma insight
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
July 14, 2023
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
March 14, 2024
by Andrii Buvailo
Biopharma insight
2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope …
March 4, 2024
by Andrii Buvailo
Biopharma insight
The biotech industry has been witnessing a paradigm shift in recent years as it moves away from traditional clinical trials …
April 8, 2024
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
Aug. 1, 2023
by Andrii Buvailo
Biopharma insight
As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that …
March 18, 2024
by Irina Bilous
Biopharma insight
Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …
Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 …
Feb. 23, 2024
by Andrii Buvailo, PhD
Interview
In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia …